Home > Drug Search >
  • company_query: ARMO Biosciences
  •   > 
Drug Filter
Category:
chemistry (8) biology (18)
Status:
Approved (2) NDA Filing (1) Phase Ⅲ (6) Phase Ⅱ (13) Phase Ⅰ (4)
Clinical Stage:
Pending (1) Active (20) Discontinued (3)
Bio-Type:
Gene therapy (1) Vaccine (9) Recombinant enzyme (1) Recombinant cytokines (1) Recombinant hormone (1) Bispecific antibody (1) Whole antibody (2) Fusion protein (1)
Indication:
Acute myeloid Leukemia (AML) (1) Anemia (1) Breast cancer (1) Chronic myeloid leukemia (CML ) (1) Crohn's disease (1) Duchenne muscular dystrophy (DMD) (2) Gynaecological disorders (1) Glaucoma (2) HIV infection (2) Malignancies (1) Melanoma (1) Multiple myeloma (MM) (1) Myelodysplastic syndrome (MDS) (1) Non small cell lung cancer (NSCLC) (1) Ocular hypertension (1) Pancreatic cancer (3) Pneumonia (1) Diphtheria (1) Pertussis (2) Tetanus (1) Rheumatoid arthritis (RA) (1) Solid tumours (1) Rotavirus infection (1) Type 2 diabetes (1) Ulcerative colitis (1) Fabry disease (1) Malignant Ascites (1) Biliary cancer (1) B-cell lymphoma (1) Infertility (1) Sporadic inclusion body myositis (sIBM) (1) Glioblastoma (1) Glioma (1) Esophagus cancer (1) Plaque psoriasis (1) Liver cancer (1) High-grade cervical intraepithelial neoplasia (1) Inflammation (1) Immunological disorders (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top